2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
527
Other hematologic neoplasm
320
Thoracic
296
CNS
132
Sarcoma
101
Genitourinary
62
Plasma cell
53
Myeloid
49
Other solid neoplasm
42
Gynecologic
39
Dermatologic
30
Breast
22
Classical hematology
21
Endocrine
19
Gastrointestinal
15
Tumor-Agnostic
7
Head & Neck
7
NET
6
Other neoplasm
3
Other
1
Conditions
Mucositis
1
Leukemia
1
Interventions
Exercise
28
Metformin
24
Surveys and Questionnaires
19
Radiotherapy
14
Methods
14
Early Intervention, Educational
13
Counseling
13
Educational Status
12
naloxegol
10
Standard of Care
10
Tirzepatide
9
Nutrition Assessment
9
Diet Therapy
9
Cisplatin
9
Resistance Training
8
Psychiatric Rehabilitation
8
Diet
8
Therapeutics
7
Interviews as Topic
7
alvimopan
6
Liraglutide
6
Fibroblast Growth Factor 7
6
Caloric Restriction
6
semaglutide
5
Radiation
5
Low-Level Light Therapy
5
Injections
5
Exenatide
5
Diet, Mediterranean
5
Dexamethasone
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Etoposide
×
Other
×
Clear all
NCT01085617
2025-03-30
UKALL14
University College, London
Completed